Search results
Annovis Bio (ANVS) Begins Dosing in Phase III Parkinson's Study
Zacks via Yahoo Finance· 2 years agoAnnovis Bio ANVS announced the dosing of the first patient in a phase III study evaluating the...
Acer (ACER) to Get Acquired by Zevra for $91M, Stock Up
Zacks via Yahoo Finance· 9 months agoAcer Therapeutics ACER announced its definitive agreement to be acquired by Zevra Therapeutics ZVRA,...
Mirum's (MIRM) Livmarli Gets FDA Nod for Expanded Use, Stock Up
Zacks via Yahoo Finance· 1 year agoMirum Pharmaceuticals MIRM announced that the FDA has approved Livmarli (maralixibat) oral solution...
Coherus (CHRS) Stock Rises on BLA Re-Filing for Udenyca Onbody
Zacks via Yahoo Finance· 8 months agoCoherus BioSciences, Inc. CHRS shares were up 8.1% on Friday after the company announced that it has...
Bicycle (BCYC) up on Collaboration With Novartis for Conjugates
Zacks via Yahoo Finance· 1 year agoBicycle (BCYC) and Novartis enter into a collaboration agreement to develop, manufacture and...
Novo Nordisk (NVO) Up on Positive Kidney Outcomes Study Update
Zacks via Yahoo Finance· 8 months agoNovo Nordisk (NVO) is set to stop its kidney outcomes study on Ozempic based on interim analysis...
3 Biotech Stocks to Buy Before Drug Trials End
InvestorPlace via Yahoo Finance· 10 months agoClinical trials can be like a tightrope over a minefield for biotech investors. Only a fraction of drugs even succeed through clinical trials to receive...
Pharming (PHAR) Rare Disease Drug Joenja Gets FDA Nod, Stock Up
Zacks via Yahoo Finance· 1 year agoPharming Group (PHAR) obtains FDA approval for leniolisib for the treatment of a rare pediatric...
DiaMedica (DMAC) Up as Stroke Study Dosing Begins Post Relaunch
Zacks via Yahoo Finance· 1 month agoDiaMedica (DMAC) rises 10% as it doses the first patient in the relaunch of its pivotal study...
Intra-Cellular (ITCI) Up as Depression Drug Meets Study Goals
Zacks via Yahoo Finance· 1 month agoIntra-Cellular (ITCI) jumps 23% after achieving key goals in the late-stage study evaluating...
